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T 
The in vitro susceptibility was determined 
of 274 isolates to cephalothin and two new 
antibiotics, cefamandole and cefoxitin. 
Cefamandole was comparable to ce-
phalothin in preventing growth of cultures 
of the gram positive organisms except for 
penicillin-resistant Staphylococcus aureus 
which was more sensitive to cephalothin. 
Cefamandole was more active than 
cephalothin against all the gram negative 
bacteria including Haemophilus influenzae 
and in addition it was active against many 
strains of Enterobacter sp. Cefoxitin was less 
active than cephalothin against the gram 
positive organisms but It was more active 
against most of the gram negative bacteria. 
In addition. It was active against Serratiaand 
indole positive Proteus which are uniformly 
resistant to cephalothin. 
* Division of Infectious Diseases, Department of 
Medicine 
Address reprint requests to Dr. del Busto at Henry 
Ford Hospital, 2799 West Grand Boulevard, De-
troit Ml 48202 
HE cephalosporin antibiotics have a wide 
spectrum of activity against gram positive 
and gram negative bacteria. However, cer-
tain Enterobacteriaceae such as Serrada, En-
terobacter and indole positive Proteus are 
resistant to the commerc ia l l y avai lable 
cephalosporins. This resistance is related, at 
least in part, to the susceptibility of the 
antibiotics to hydrolysis by the/3-lactamases 
produced by these gram negative orga-
nisms.'-^ In the case of Pseudomonas 
aeruginosa the resistance to ;8-lactam antibi-
otics seems to be primarily due to an intrinsic 
resistance rather than to /S-lactamase.^ 
Two investigational antibiotics: cefaman-
dole, a new cephalosporin and cefoxitin, a 
cephamycin derivative, have been shown to 
have a wider spectrum of activity against 
gram negative organisms than the currently 
available cephalosporins."^' In addition, 
cefoxitin is also active against Bacteroides 
fragllis wh ich is usually resistant to the 
cephalosporin antibiotics." Cefoxitin has an 
increased resistance to inactivation by the ;S-
lactamase of certain gram negative bacteria 
probably related to the presence of an alpha 
methoxy group in position C7 of its lactam 
ring' (Figure 1). 
The purpose of this study was to compare 
the in vitro activity of cefamandole and 
cefoxitin with that of cephalothin against 
recent isolates of bacteria from Henry Ford 
Hospital. 
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CEPHALOTHIN 
CHg.CO.NH 
r CH2.0.C0.CH3 
COO- Na+ 
CEFOXITIN 
11 ILCHp.CO.NH 
s 
-N~..,,^s=^ CH2.0.C0.NH2 
COO" Na+ 
Figure 1 
Chemical structure of cephalothin and cefoxitin. 
Material and methods 
The activity of cefamandole, cefoxitin and 
cephalothin against 274 isolates was deter-
mined by the agar dilution method'" utiliz-
ingMueller-Hinton agar (BBL), except in the 
case of Haemophilus influenzae where GC 
Medium Base (BBL)was used. Inoculation of 
the agar plates, containingtwofold dilutions 
of the antibiotics, was performed using the 
Steers replicator." Approximately 10' orga-
nisms were delivered to each plate for each 
representative organ ism. The minimal inhib-
itory concentration (MIC) was defined as the 
lowest concentration of antibiotic which 
prevented visible growth after 18 hours of 
incubation (24 hours for H. influenzae) at 
37°C. The susceptibility of the following 
bacteria was determined: 39 strains of £s-
cherichia coli (including 19 cephalothin-
resistant strains), 24 strains each of penicill in 
resistantStaphy/ococcus aureus, Proteus mi-
rabllls, Klebsiella sp., and Streptococcus 
faecalls, 23 strains of P. aeruginosa, 22 
strainsof group A beta hemolytic streptococ-
cus, 20 strains of penicillin sensitive Sta-
phylococcus aureus, 18 strains of alpha 
streptococcus, 15 strains each of indole posi-
tive Proteus and H. influenzae, 14 strains of 
Enterobacter sp., and 12 of Serratia sp. 
Disc susceptibility testing was done ac-
cording to the standardized disc technique 
recommended by the Food and Drug Ad-
ministration.'^-'^ Thirty microgram discs 
were used for the three antibiotics. The zone 
diameters were then plotted against the MIC 
values obtained with the agar dilution meth-
od, and a regression line was calculated by 
the method of least squares. 
Results and discussion 
Tablel compares the MlC'sand the zones 
of inhibition of the three antibiotics against 
the gram positive organisms tested. It can be 
seen that cefamandole was as active as 
cephalothin against all of them except pen-
icillin resistant 5. aureus which was more 
sensitive to cephalothin. Cefoxitin was less 
active than cephalothin against all the gram 
positive organisms tested. All three antibiot-
ics were inactive against S. faecalls. 
Table 2 compares theMlC's and the zones 
of inhibition of the three antibiotics against 
the gram negative organisms. Cefamandole 
was more active than cephalothin against all 
the gram negative bacteria including H. 
influenzae, and in addition it was active 
against many strains of Enterobacter sp. 
Cefamandole was more active than cefoxitin 
against all the gram negative bacteria except 
Serratia sp. and indole positive Proteus. 
Cefoxitin compared favorably with 
cephalthin and in addition it was active 
against Serrada sp. and indole positive Pro-
teus. All three antibiotics were inactive 
against P. aeruginosa. 
Figures 2 to 8 show the activity ofthe three 
antibiotics against some of the organisms 
tested, expressed as cumulative percent of 
strains inhibited at increasing MIC's. One 
hundred percent of strains of group A beta 
hemolytic streptococcus were inhibited by 
0.048 Mg/ml of cefamandole, 0.39 p.g/m\ 
of cephalothin and 0.78 /u.g/ml of cefoxitin 
(Figure 2). All strainsof penicillin resistantS. 
aureus were inhibited by 0.39 p g / m \ of 
cephalothin, whereas 3.1 / i g /m l of cefa-
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Table 1. 
In Vitro Activity of Cefamandole, Cefoxitin and 
Cephalothin Against Gram Positive Organisms 
Cefamandole Cefoxitin Cephalothin 
Organisms and MIC Zone of MIC Zone of MIC Zone of 
Number of Strains (yag/ml) Inhibition" (/uig/ml) Inhibition (/ag/ml) Inhibition 
(mm) (mm) (mm) 
Group A hemolytic 
streptococcus (22) <0.033 41.8 0.625 34.0 <0.075 34.9 
S. aureus 
Penicillin res. (24) 0.984 27.6 3.51 29.2 0.329 31.3 
Penicillin sen. (20) 0.209 40.2 2.61 30.1 0.193 39.5 
Alpha streptococcus (18) 0.143 43.9 1.82 32.7 0.389 37.7 
S. faecalls (24) 34.3 12.9 50.0 6 25,C 14.9 
'Geometric mean 
"Arithmetic mean 
Table 2. 
In Vitro Activity of Cefamandole, Cefoxitin and 
Cephalothin Against Gram Negative Organisms 
Cefamandole Cefoxitin Cephalothin 
Organisms and MIC Zone of MIC Zone of MIC Zone of 
Number of Strains (Mg/ml) Inhibition'' {pglmi) Inhibition {pglm\) Inbibition 
(mm) (mm) (mm) 
E. coli (20 0.984 26.5 3.71 26.1 8.47 17.6 
Klebsiella sp. (24) 1.43 25.5 4.95 22.8 4.60 21.4 
Enterobacter sp (14) 7.99 23.4 >33.6 10.6 >50 6.0 
P. mirabilis (24) 0.989 28.2 2.77 23.9 5.14 24.5 
Indole positive 
Proteus (15) >17.3 16.5 8.63 19.3 >50 6.0 
Serratia sp. (12) >26.5 14.9 18.7 17.6 >50 6.0 
P. aeruginosa (23) >50 6.0 >50 6.0 >50 6.0 
H. influenzae (15) 0.389 26.2 6.84 21.1 1.70 23.1 
'Geometric mean 
"Arithmetic mean 
mandole and 6.2 /ag/ml of cefoxitin were 
needed to inhibit all strains (Figure 3). 
Against E. coll, a concentration of 1.56 
p g / m l of cefamandole inhibited 90% of 
strains, whereas at the same concentration, 
only about 20% of strains were inhibited by 
cephalothin and cefoxitin (Figure 4). We also 
tested 19 strains of cephalothin resistant E. 
coli {not shown in the graph), and found that 
both cefamandole and cefoxitin inhibited 
about50% of them at a concentration of 12.5 
p g / m l . This concentration can be readily 
achieved with doses of cefamandole and 
cefoxitin recommended in current clinical 
trials. Previous studies have shown that the 
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CEPHALOTHIN 
CEFOXITIN O O 
/ CEFAMANDOLE A A 
< 0 .024 0.024 0.048 0 .096 0.195 0.39 
ANTIBIOTIC CONCENTRATION ( ^ g / m l ) 
0.78 
Figure 2 
Cumulative percentage of group A hemolytic streptococcus inhibited by increasing concentrations of 
cefamandole, cefoxitin and cephalothin. 
CEPHALOTHIN • • 
CEFOXITIN O O 
CEFAMANDOLE A A 
0 . 0 9 6 0.195 0 .39 0.78 1.56 
T— 
3.1 6.2 
ANTIBIOTIC CONCENTRATION ( ^ g / m l ) 
Figure 3 
Cumulative percentage of penicil l in resistant S. aureus inhibited by increasing concentrations of 
cefamandole, cefoxitin and cephalothin. 
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0 097 0.195 0 39 >50 
ANTIBIOTIC CONCENTRATION ( / ig /ml ) 
Figure 4 
Cumulative percentage o f f . coli inhibited by increasing concentrations of cefamandole, cefoxitin and 
cephalothin. 
0.195 0.39 0.78 1.56 3.1 6.2 12.5 
ANTIBIOTIC CONCENTRATION ( / i g / m l ) 
Figure 5 
Cumulative percentage of Enterobacter sp. inhibited by increasing concentrations of cefamandole, 
cefoxitin and cephalothin. 
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6.2 12.5 25 50 
ANTIBIOTIC CONCENTRATION ( ^ g / m l ) 
> 5 0 
Figure 6 
Cumulative percentage of Serratia sp. inhibited by increasing concentrations of cefamandole, cefoxitin 
and cephalothin. 
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CEFOXITIN O O 
CEFAMANDOLEA 
3.1 6.2 12.5 25 
ANTIBIOTIC CONCENTRATION ( / x g / m l ) 
Figure 7 
Cumulative percentage of indole positiveProfeus inhibited by increasing concentrations of cefamandole, 
cefoxitin and cephalothin. 
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Figure 8 
Cumulative percentage of H. influenzae inhibited by increasing concentrations of cefamandole, cefoxitin 
and cephalothin. 
peak serum levels of cefamandole and 
cefox i t in are comparable to those of 
cephalothin and their serum half lives are 
more prolonged.^-^"''^ 
Against Enterobacter sp., cefamandole at 
a concentration of 12.5 pg/ rn l inhibited 
70% of strains, whereas cefoxitin inhibited 
15% and cephalothin inhibited none of them 
(Figure 5). AgainstSerrat/a sp., cefoxitin was 
the most active antibiotic, and at a con-
centration of 12.5 p g / m l , itinhibited 60% of 
strains while cefamandole inhibited only 
15% and cephalothin was uniformly inactive 
(Figure 6). Cefoxitin was also the most active 
against indole positive Proteus; at a con-
centration of 12.5/ag/ml it inhibited 85% of 
strains, while cefamandole inhibited only 
half of the strains and cephalothin none of 
them (Figure 7). All strains of H. influenzae 
were inhibited by 12.5 p g / m l or less of the 
three antibiotics. However, cefamandole 
was much more active, and at a concentra-
tion of less than 1 p g / m l , it inhibited all 
strains (Figure 8). 
Disc susceptibility tests: Using the estab-
lished criteria for all cephalosporin antibiot-
ics (i.e., that a zone of inhibition of 18 mm or 
more, with a 30 pg antibiotic disc, indicates 
susceptibility) we found that all the gram 
positive organ isms tested (excepts, faecalls) 
were susceptible to the three antibiotics. 
With the gram negative organisms, however, 
we found that 72% of the isolates were 
sensitive to cefoxitin, 68% to cefamandole 
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ICS AGAR 
DIAMETER 
MIC 
Log2N (/xg/ml) 
KLEBSIELLA SP 
ENTEROBACTER SP 
INDOLE POS. PROTEUS 
R MIRABILIS 
SERRATIA SR 
E. COLI 
H, INFLUENZAE 
R AERUGINOSA 
ALPHA STREPTOCCUS 
(8 STREP (GROUP A) 
S AUREUS (PCN RESISTANT) 
S. AUREUS (PCN SENSITIVE) 
S. FAECALIS 
ZONE DIAMETER (mm) 
Figure 9 
Regression line correlating disc zone sizes with MIC's of cefamandole. 
and only 47% were sensitive to cephalothin. 
The greater number of susceptible organisms 
to cefoxitin and cefamandole was related 
mainly to the increased susceptibility of 
Serratia sp. indole positive Proteus, Entero-
bacter sp. and E. coli. 
The correlation of activity of cefamandole 
and cefoxitin asdetermined bythe standard-
ized disc technique and the agar dilution 
method is shown in Figures 9 and 10. The 
regression curve for cefamandole shows that 
the accepted cutoff point for susceptibil ity of 
the cephalosporins (18 mm), corresponds to 
an MIC value of 10 p g / m l (Figure 9). For 
cefoxitin an 18 mm inhibition zone corre-
sponds to an MIC of 12.5 / i g / ml. It should be 
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35 45 
Figure 10 
Regression line correlating disc zone sizes with MIC's of cefoxitin. 
kept in mind, however, that before establish-
inga zone diameter and MIC value to define 
susceptibility of an organism to any antibiot-
ic, we must await the results of clinical trials 
with the antibiotic. 
In conclusion, this study demonstrates 
that cefamandole and cefoxitin have an 
increased in vitro activity as compared to 
cephalothin, especially against the gram 
negative bacteria. This data indicates that 
clinical trials with these two new antibiotics 
are warranted. 
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